Interpatient and intrapatient variability in organ absorbed doses during [177Lu]Lu-DOTATATE therapy for neuroendocrine tumors

Malgorzata Poniatowska-Roszkowska, Hanna Piwowarska-Bilska, Mikołaj Roszkowski, Bożena Birkenfeld

Open source

DOI
10.5603/nmr.114542
Published
2026-04-20
Container
Nuclear Medicine Review
Publisher
VM Media Group sp. z o.o
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5603/nmr.114542,
  title = {Interpatient and intrapatient variability in organ absorbed doses during [177Lu]Lu-DOTATATE therapy for neuroendocrine tumors},
  author = {Malgorzata Poniatowska-Roszkowska and Hanna Piwowarska-Bilska and Mikołaj Roszkowski and Bożena Birkenfeld},
  year = {2026},
  journal = {Nuclear Medicine Review},
  doi = {10.5603/nmr.114542},
  url = {https://doi.org/10.5603/nmr.114542}
}

RIS

TY  - JOUR
TI  - Interpatient and intrapatient variability in organ absorbed doses during [177Lu]Lu-DOTATATE therapy for neuroendocrine tumors
AU  - Malgorzata Poniatowska-Roszkowska
AU  - Hanna Piwowarska-Bilska
AU  - Mikołaj Roszkowski
AU  - Bożena Birkenfeld
PY  - 2026
JO  - Nuclear Medicine Review
DO  - 10.5603/nmr.114542
UR  - https://doi.org/10.5603/nmr.114542
ER  - 

APA

Poniatowska-Roszkowska, M., Piwowarska-Bilska, H., Roszkowski, M., & Birkenfeld, B. (2026). Interpatient and intrapatient variability in organ absorbed doses during [177Lu]Lu-DOTATATE therapy for neuroendocrine tumors. Nuclear Medicine Review. https://doi.org/10.5603/nmr.114542

Source records